Vor Biopharma Inc.
Calidad de datos: 83%
VOR
Nasdaq
Manufacturing
Chemicals
$15.52
▼
$0.23
(-1.43%)
Cap. Mercado: 758.11 M
Precio
$15.52
Cap. Mercado
758.11 M
Rango del Día
$15.50 — $16.39
Rango de 52 Semanas
$2.62 — $65.80
Volumen
617,795
Apertura $15.60
Promedio 50D / 200D
$14.26
8.82% above
Promedio 50D / 200D
$23.90
35.07% below
Quick Summary
Puntos Clave
Negative free cash flow of -143.65 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC-193.16%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio9.16
Interest CoverageN/A
Valoración
PE (TTM)
-1.09
Above sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.1 | -2.0 |
| P/B | — | 5.1 |
| ROE % | — | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -695.98 M |
| ROE | N/A | ROA | -364.76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -143.65 M |
| ROIC | -193.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 9.16 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 153.65 M | Tangible Book Value | -2.23 B |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.09 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -18.95% | ||
| Market Cap | 758.11 M | Enterprise Value | 597.65 M |
| Per Share | |||
| EPS (Diluted TTM) | -70.50 | Revenue / Share | N/A |
| FCF / Share | -2.94 | OCF / Share | -2.92 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 20.64% |
| SBC-Adj. FCF | -157.72 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -695.98 M | -116.91 M | -117.86 M | -92.09 M | -68.90 M |
| EPS (Diluted) | -70.50 | -1.70 | -1.75 | -2.33 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -371.64 M | -121.19 M | -126.04 M | -93.42 M | -69.02 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 321.53 M | 93.31 M | 94.32 M | 64.55 M | 47.53 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 464.13 M | 142.89 M | 198.13 M | 299.37 M | 242.59 M |
| Total Liabilities | 628.44 M | 46.23 M | 47.40 M | 48.76 M | 26.33 M |
| Shareholders' Equity | -164.31 M | 96.66 M | 150.72 M | 250.61 M | 216.26 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 396.49 M | 81.95 M | 31.36 M | 57.71 M | 119.80 M |
| Current Assets | 458.11 M | 96.51 M | 140.80 M | 236.95 M | 214.40 M |
| Current Liabilities | 25.17 M | 18.61 M | 15.57 M | 13.12 M | 10.15 M |
{"event":"ticker_viewed","properties":{"ticker":"VOR","listing_kind":"stock","pathname":"/stocks/vor","exchange":"Nasdaq","country":"US"}}